These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

899 related articles for article (PubMed ID: 16939702)

  • 21. Experimental dual infection of pigs with an H1N1 swine influenza virus (A/Sw/Hok/2/81) and Mycoplasma hyopneumoniae.
    Yazawa S; Okada M; Ono M; Fujii S; Okuda Y; Shibata I; Kida H
    Vet Microbiol; 2004 Mar; 98(3-4):221-8. PubMed ID: 15036530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serological profiles after consecutive experimental infections of pigs with European H1N1, H3N2, and H1N2 swine influenza viruses.
    Van Reeth K; Labarque G; Pensaert M
    Viral Immunol; 2006; 19(3):373-82. PubMed ID: 16987057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety, immunogenicity and efficacy of poxvirus-based vector vaccines expressing the haemagglutinin gene of a highly pathogenic H5N1 avian influenza virus in pigs.
    Kyriakis CS; De Vleeschauwer A; Barbé F; Bublot M; Van Reeth K
    Vaccine; 2009 Apr; 27(16):2258-64. PubMed ID: 19428840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of commercial swine influenza vaccines against challenge with a recent European H1N1 field isolate.
    Kyriakis CS; Gramer MR; Barbé F; Van Doorsselaere J; Van Reeth K
    Vet Microbiol; 2010 Jul; 144(1-2):67-74. PubMed ID: 20116942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
    Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
    Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective efficacy of intranasally administered bivalent live influenza vaccine and immunological mechanisms underlying the protection.
    Pyo HM; Zhou Y
    Vaccine; 2014 Jun; 32(30):3835-42. PubMed ID: 24837774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge.
    Breathnach CC; Clark HJ; Clark RC; Olsen CW; Townsend HG; Lunn DP
    Vaccine; 2006 Feb; 24(8):1180-90. PubMed ID: 16194586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of maternally-derived antibodies on live attenuated influenza vaccine efficacy in pigs.
    Pyo HM; Hlasny M; Zhou Y
    Vaccine; 2015 Jul; 33(31):3667-72. PubMed ID: 26092308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlations between lung proinflammatory cytokine levels, virus replication, and disease after swine influenza virus challenge of vaccination-immune pigs.
    Van Reeth K; Van Gucht S; Pensaert M
    Viral Immunol; 2002; 15(4):583-94. PubMed ID: 12513929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seroprevalence and genetic evolutions of swine influenza viruses under vaccination pressure in Korean swine herds.
    Pascua PN; Song MS; Lee JH; Choi HW; Han JH; Kim JH; Yoo GJ; Kim CJ; Choi YK
    Virus Res; 2008 Dec; 138(1-2):43-9. PubMed ID: 18789984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity and efficacy of a recombinant adenovirus expressing hemagglutinin from the H5N1 subtype of swine influenza virus in mice.
    Wu Y; Qiao C; Yang H; Chen Y; Xin X; Chen H
    Can J Vet Res; 2014 Apr; 78(2):117-26. PubMed ID: 24688173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fusion of C3d with hemagglutinin enhances protective immunity against swine influenza virus.
    Li GX; Tian ZJ; Yu H; Jin YY; Hou SH; Zhou YJ; Liu TQ; Hu SP; Tong GZ
    Res Vet Sci; 2009 Jun; 86(3):406-13. PubMed ID: 19010505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge.
    Minke JM; Toulemonde CE; Coupier H; Guigal PM; Dinic S; Sindle T; Jessett D; Black L; Bublot M; Pardo MC; Audonnet JC
    Am J Vet Res; 2007 Feb; 68(2):213-9. PubMed ID: 17269889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.
    Tao P; Luo M; Pan R; Ling D; Zhou S; Tien P; Pan Z
    Antiviral Res; 2009 Mar; 81(3):253-60. PubMed ID: 19135483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
    Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
    Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of hemagglutination-inhibition titers to influenza A virus in porcine sera by use of an enzyme-linked immunosorbent assay.
    Lee BW; Bey RF; Baarsch MJ; Morrison RB; Freese W
    Am J Vet Res; 1993 Aug; 54(8):1270-6. PubMed ID: 8214894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine.
    Vincent AL; Ma W; Lager KM; Janke BH; Webby RJ; García-Sastre A; Richt JA
    Vaccine; 2007 Nov; 25(47):7999-8009. PubMed ID: 17933442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental challenge of pregnant gilts with swine influenza virus after vaccination.
    Woods GT; Mansfield ME
    Res Commun Chem Pathol Pharmacol; 1976 Dec; 15(4):787-95. PubMed ID: 188087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the humoral immune response of experimentally infected and vaccinated pigs to swine influenza viral proteins.
    Kim WI; Wu WH; Janke B; Yoon KJ
    Arch Virol; 2006 Jan; 151(1):23-36. PubMed ID: 16132180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pandemic H1N1 influenza virus-like particles are immunogenic and provide protective immunity to pigs.
    Pyo HM; Masic A; Woldeab N; Embury-Hyatt C; Lin L; Shin YK; Song JY; Babiuk S; Zhou Y
    Vaccine; 2012 Feb; 30(7):1297-304. PubMed ID: 22207090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.